Schiller M - Search Results

1

Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma.

Hüsken AC, Tsianakas A, Hensen P, Nashan D, Loquai C, Beissert S, Luger TA, Sunderkötter C, Schiller M. Hüsken AC, et al. Among authors: schiller m. J Eur Acad Dermatol Venereol. 2012 Jan;26(1):71-8. doi: 10.1111/j.1468-3083.2011.04011.x. Epub 2011 Mar 9. J Eur Acad Dermatol Venereol. 2012. PMID: 22168776

2

Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas.

Loquai C, Nashan D, Hensen P, Luger TA, Grabbe S, Sunderkötter C, Schiller M. Loquai C, et al. Among authors: schiller m. Eur J Dermatol. 2008 Jan-Feb;18(1):29-35. doi: 10.1684/ejd.2008.0307. Epub 2007 Dec 18. Eur J Dermatol. 2008. PMID: 18086586

3

Quality of life in melanoma patients during adjuvant treatment with pegylated interferon-α2b: patients' and doctors' views.

Loquai C, Schmidtmann I, Beutel M, Sunderkötter C, Grabbe S, Schiller M, Nashan D. Loquai C, et al. Among authors: schiller m. Eur J Dermatol. 2011 Nov-Dec;21(6):976-84. doi: 10.1684/ejd.2011.1514. Eur J Dermatol. 2011. PMID: 21896421

4

Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma.

Schiller M, Tsianakas A, Sterry W, Dummer R, Hinke A, Nashan D, Stadler R. Schiller M, et al. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1841-1847. doi: 10.1111/jdv.14366. Epub 2017 Jul 20. J Eur Acad Dermatol Venereol. 2017. PMID: 28557110

5

Dermatomyositis associated with malignant melanoma--a marker of poor prognosis?

Schiller M, Böhm M, Hensen P, Riemann H, Luger TA, Nashan D. Schiller M, et al. J Am Acad Dermatol. 2006 Feb;54(2):221-6. doi: 10.1016/j.jaad.2005.10.026. J Am Acad Dermatol. 2006. PMID: 16443051

6

Predisposing factors of actinic keratosis in a North-West German population.

Hensen P, Müller ML, Haschemi R, Ständer H, Luger TA, Sunderkötter C, Schiller M. Hensen P, et al. Among authors: schiller m. Eur J Dermatol. 2009 Jul-Aug;19(4):345-54. doi: 10.1684/ejd.2009.0706. Epub 2009 May 25. Eur J Dermatol. 2009. PMID: 19470418

7

The option of compassionate use in metastatic melanoma - way out of a therapeutic dilemma?

Tsianakas A, Schiller M, Luger TA, Sunderkötter C. Tsianakas A, et al. Among authors: schiller m. J Dtsch Dermatol Ges. 2009 Aug;7(8):671-9. doi: 10.1111/j.1610-0387.2009.07028.x. J Dtsch Dermatol Ges. 2009. PMID: 19708953 Review. English, German.

8

Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors.

Böhm M, Schiller M, Nashan D, Stadler R, Luger TA, Metze D. Böhm M, et al. Among authors: schiller m. J Am Acad Dermatol. 2001 May;44(5):747-54. doi: 10.1067/mjd.2001.112349. J Am Acad Dermatol. 2001. PMID: 11312419

9

Terbinafine-induced subacute cutaneous lupus erythematosus.

Bonsmann G, Schiller M, Luger TA, Ständer S. Bonsmann G, et al. Among authors: schiller m. J Am Acad Dermatol. 2001 Jun;44(6):925-31. doi: 10.1067/mjd.2001.114565. J Am Acad Dermatol. 2001. PMID: 11369902

10

Skin metastases in metastatic uveal melanoma: GNAQ/GNA11 mutational analysis as a valuable tool.

Tsianakas A, Böhm MR, Getova V, Metze D, Eter N, Spieker T, Bräuninger A, Luger T, Schiller M, Sunderkötter C. Tsianakas A, et al. Among authors: schiller m. Br J Dermatol. 2013 Jul;169(1):160-3. doi: 10.1111/bjd.12291. Br J Dermatol. 2013. PMID: 23464620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters